Discover
NVCT
Nuvectis Pharma, Inc.
19.52
2 x 14.46
2 x 23.87
bid
ask
+
1.13
6.14%
2 @ 04:58 AM
19.99 +0.47 (2.41%)
| Ytd | 158.54% | |
| 1y | 159.57% |
18.42
day range
20.20
5.55
52 week range
29.27
| Open | 18.61 | Prev Close | 18.39 | Low | 18.42 | High | 20.20 | Mkt Cap | 615.38M |
| Vol | 899.20K | Avg Vol | 217.34K | EPS | -1.31 | P/E | N/A | Forward P/E | -4.77 |
| Beta | 0.40 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 12.14 | 200-d Avg | 8.63 | 1yr Est | 22.00 |
| Income Statement | |||
| Operating Expenses | 6.26M | ||
| Research and Development Expense | 4.11M | ||
| Selling, General and Administrative Expense | 2.15M | ||
| Operating Income | -6.26M | ||
| Net Income | -6.05M | ||
| Net Income Common Stock | -6.05M | ||
| Net Income Common Stock (USD) | -6.05M | ||
| Consolidated Income | -6.05M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -6.05M | ||
| Earning Before Interest & Taxes (USD) | -6.05M | ||
| Weighted Average Shares | 23.41M | ||
| Weighted Average Shares Diluted | 23.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 25.13M | ||
| Cash and Equivalents (USD) | 25.13M | ||
| Current Assets | 25.40M | ||
| Total Assets | 25.40M | ||
| Current Liabilities | 11.18M | ||
| Total Liabilities | 11.18M | ||
| Accumulated Retained Earnings (Deficit) | -105.74M | ||
| Shareholders Equity | 14.22M | ||
| Shareholders Equity (USD) | 14.22M | ||
| Trade and Non-Trade Payables | 4.70M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 7.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.50M | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Net Cash Flow from Operations | -6.51M | ||